Concepedia

Xiao Fang

XF

Statistics

Publications

57

Citations

3.6K

H-Index

30

Active since

1996

Affiliations

University of Tennessee Health Science Center(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Hamamatsu University School of Medicine

National Cancer Institute

NYU Langone Health

Xiao Fang is an author at University of Tennessee Health Science Center specializing in medicine, pharmacology, and oncology.

Publications per year

1996–2025

57

Publications

57

Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan

Takahisa Furuta, Emad El‐Omar, Xiao Fang et al. · Gastroenterology · 2002 · 347 citations · Full text

Life Sciences, Genetics, Immunology +17

Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study

Kohei Shitara, Sun Young Rha, Lucjan Wyrwicz et al. · The Lancet Oncology · 2023 · 339 citations

Medicine, Oncology, Pharmacology +16

Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer

Jacqueline Vuky, Arjun Vasant Balar, Daniel Castellano et al. · Journal of Clinical Oncology · 2020 · 292 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Imaging peptidoglycan biosynthesis in <i>Bacillus subtilis</i> with fluorescent antibiotics

Kittichoat Tiyanont, Thierry Doan, Michael B. Lazarus et al. · Proceedings of the National Academy of Sciences · 2006 · 249 citations · Full text

Life Sciences, Microbiology, Molecular Biology +14

Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection

Weibing Yin, Mingguang Yan, Xiao Fang et al. · Clinica Chimica Acta · 2017 · 192 citations

Medicine, Molecular Biology, Oncology +15

1–5 of 57